GENE ONLINE|News &
Opinion
Blog

2021-01-24| ChinaCOVID-19

Expecting Lunar New Year Travel Rush, China Races to Build Giant Quarantine Center

by Tyler Chen
Share To

Outside Shijiazhuang, Hebei province, over 4,000 construction workers are building a giant quarantine center of 4,156 units that can house COVID-19 patients within days of diagnosis.

 

New Wave of COVID-19 Cases

According to WHO’s data, China has 99,414 confirmed cases of COVID-19 with 4,808 deaths as of January 21st. As the Lunar New Year approaches, China expects a new wave of COVID-19 cases where city residents are traveling across the country to meet their families. To alleviate the burden on the healthcare system, China has started constructing a new quarantine location on January 13th on the outskirts of Northern China.

 

Quarantine Unit

Each unit in the quarantine center is equipped with basic facilities, including internet, bathroom, bedroom, air conditioning, etc. District 1 is currently moving to the last phase. Most of the infrastructures are done with air conditioning and water heaters waiting to be installed. Within days, China has successfully delivered 606 units and is estimated to reach 1,779 in total by the end of January.

 

Individual Testing of COVID-19

Furthermore, China has scheduled to perform a COVID-19 testing plan in the quarantine center for each individual. Every personnel and quarantine related parties will undergo a nucleic acid amplification testing (NAAT) for COVID-19 from January 20 to 22nd, and there will be 28 testing companies for professional and efficient screening.

Related Article: COVID-19: South Korea and Japan Make New Plans to Fight the Pandemic

References
  1. http://www.gov.cn/xinwen/2021-01/19/content_5581124.htm#1
  2. http://www.sjz.gov.cn/col/1609405465981/2021/01/21/1611190892875.html
  3. http://www.sjz.gov.cn/col/1596014213243/2021/01/20/1611105496040.html
  4. https://www.163.com/dy/article/G0SLI3JB0514R9KE.html

 

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
R&D
Breakthrough Screening Platform to Assess SARS-CoV-2 Mutations and Potential Treatments
2024-04-16
BIO CHINA 2024 Brings Biotech Experts and Industry Elites Together for Innovation
2024-03-27
Major U.S. Organization BIO Severs Ties With Member WuXi AppTec Amid U.S. Government’s Security Concerns
2024-03-15
LATEST
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
EVENT
Scroll to Top